AV 3208Alternative Names: AV-3208
Latest Information Update: 14 Nov 2013
At a glance
- Originator ChemDiv
- Developer AllaChem
- Class Methylamines; Obesity therapies; Small molecules
- Mechanism of Action Serotonin 6 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity
Most Recent Events
- 14 Nov 2013 Preclinical trials in Obesity in USA (unspecified route)